We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+1.24%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.1B
AUM Growth
+$312M
Cap. Flow
-$44.8M
Cap. Flow %
-0.37%
Top 10 Hldgs %
38.76%
Holding
1,279
New
83
Increased
328
Reduced
404
Closed
81

Sector Composition

Rank Sector Weight
1 Real Estate 72.69%
2 Technology 4.79%
3 Financials 3.72%
4 Healthcare 2.91%
5 Industrials 2.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCEL
1151
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$2K ﹤0.01%
+124
New +$1.5K
AMRS
1152
DELISTED
Amyris Inc.
AMRS
$2K ﹤0.01%
645
SPPI
1153
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$2K ﹤0.01%
638
-68
-10% -$549
TWTR
1154
PUT
DELISTED
Twitter, Inc.
TWTR
$2K ﹤0.01%
2,751
TBIO
1155
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$2K ﹤0.01%
287
AMAG
1156
DELISTED
AMAG Pharmaceuticals
AMAG
$2K ﹤0.01%
195
PDLI
1157
DELISTED
PDL BioPharma, Inc.
PDLI
$2K ﹤0.01%
644
-209
-25% -$607
ADMA icon
1158
ADMA Biologics
ADMA
$1.97B
$1K ﹤0.01%
+335
New +$1.46K
EYPT icon
1159
EyePoint Inc
EYPT
$1.04B
$1K ﹤0.01%
62
GERN icon
1160
Geron
GERN
$949M
$1K ﹤0.01%
880
CBIO
1161
Crescent Biopharma
CBIO
$626M
$1K ﹤0.01%
3
MNKD icon
1162
MannKind Corp
MNKD
$1.22B
$1K ﹤0.01%
1,042
PGEN icon
1163
PUT
Precigen
PGEN
$1.93B
$1K ﹤0.01%
1,500
PTGX icon
1164
Protagonist Therapeutics
PTGX
$8.72B
$1K ﹤0.01%
+154
New +$1.53K
SLDB icon
1165
Solid Biosciences
SLDB
$777M
$1K ﹤0.01%
20
SYRE icon
1166
Spyre Therapeutics
SYRE
$8.69B
$1K ﹤0.01%
6
WVE icon
1167
Wave Life Sciences
WVE
$1.14B
$1K ﹤0.01%
213
XERS icon
1168
Xeris Biopharma Holdings
XERS
$1.42B
$1K ﹤0.01%
170
CBAY
1169
DELISTED
Cymabay Therapeutics
CBAY
$1K ﹤0.01%
378
CHMA
1170
DELISTED
Chiasma, Inc. Common Stock
CHMA
$1K ﹤0.01%
+237
New +$1.23K
AKRX
1171
DELISTED
Akorn Inc
AKRX
$1K ﹤0.01%
792
FOMX
1172
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$1K ﹤0.01%
389
ABUS icon
1173
Arbutus Biopharma
ABUS
$871M
-304
Closed
ACET icon
1174
Adicet Bio
ACET
$75.3M
$0 ﹤0.01%
2
ACRS icon
1175
Aclaris Therapeutics
ACRS
$750M
-170
Closed

Similar funds

Daiwa Securities Group's Q4 2019 Portfolio in Review

As of Q4 2019, Daiwa Securities Group held 1,279 positions worth $12.1B, up 2.6% from $11.8B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Daiwa Securities Group's Q4 2019 filing shows 83 new, 328 increased, 404 reduced and 81 closed positions. Its largest new stake was Performance Food Group: 109,263 shares worth $5.63M. The largest sale was Sun Communities, an estimated $208M.

By sector, the portfolio is most concentrated in Real Estate at 73% of assets, down from 73% a quarter earlier, followed by Technology and Financials.

  • Daiwa Securities Group's largest Q4 2019 buy was Performance Food Group: 109,263 shares worth $5.63M.
  • Daiwa Securities Group added most to Digital Realty Trust in Q4 2019, an estimated $239M increase.
  • Daiwa Securities Group's biggest Q4 2019 reduction was Sun Communities, cutting an estimated $208M.
  • Daiwa Securities Group fully exited State Street SPDR S&P 500 ETF Trust in Q4 2019, selling an estimated $13.1M.
  • Daiwa Securities Group's ten largest holdings make up 39% of its $12.1B portfolio in Q4 2019.
  • Daiwa Securities Group opened 83 new positions and closed 81 in Q4 2019.
  • Daiwa Securities Group's portfolio value rose 2.6% quarter-over-quarter to $12.1B.

Based on Daiwa Securities Group's 13F filing for Q4 2019, filed 31 Jan 2020.